| 1 |
Wang H, Zhang M, Fang F, Xu C, Liu J, Gao L, Zhao C, Wang Z, Zhong Y, Wang X. The nuclear receptor subfamily 4 group A1 in human disease. Biochem Cell Biol 2023. [PMID: 36861809 DOI: 10.1139/bcb-2022-0331] [Reference Citation Analysis]
|
| 2 |
Wang H, Zhang M, Fang F, Xu C, Liu J, Gao L, Zhao C, Wang Z, Zhong Y, Wang X. The nuclear receptor subfamily 4 group A1 in human disease.. [DOI: 10.21203/rs.3.rs-2080533/v1] [Reference Citation Analysis]
|
| 3 |
Yang SL, Guan HQ, Yang HB, Chen Y, Huang XY, Chen L, Shen ZF, Wang LX. The expression and biological effect of NR2F6 in non-small cell lung cancer. Front Oncol 2022;12:940234. [DOI: 10.3389/fonc.2022.940234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Ning W, Xu N, Zhou C, Zou L, Quan J, Yang H, Lu Z, Cao H, Liu J. Ethyl Acetate Fraction of Hedyotis diffusa Willd Induces Apoptosis via JNK/Nur77 Pathway in Hepatocellular Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-10. [DOI: 10.1155/2022/1932777] [Reference Citation Analysis]
|
| 5 |
Pastori V, Pozzi S, Labedz A, Ahmed S, Ronchi AE. Role of Nuclear Receptors in Controlling Erythropoiesis. Int J Mol Sci 2022;23:2800. [PMID: 35269942 DOI: 10.3390/ijms23052800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Karki K, Mohankumar K, Schoeller A, Martin G, Shrestha R, Safe S. NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth. Cancers (Basel) 2021;13:2682. [PMID: 34072371 DOI: 10.3390/cancers13112682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Ding X, Zhao Z, Wu Y, Zhang H, Chen K, Luo C, Luo X, Xu H. Identification of novel anti-inflammatory Nur77 modulators by virtual screening. Bioorg Chem 2021;112:104912. [PMID: 33933804 DOI: 10.1016/j.bioorg.2021.104912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Tu X, Chen X, Zhang D, Gao M, Liang J, Bao G, Zhang J, Peng S, Zhang X, Zeng Z, Su Y. Optimization of novel oxidative DIMs as Nur77 modulators of the Nur77-Bcl-2 apoptotic pathway. Eur J Med Chem 2021;211:113020. [PMID: 33279290 DOI: 10.1016/j.ejmech.2020.113020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Chen L, Fan F, Wu L, Zhao Y. The nuclear receptor 4A family members: mediators in human disease and autophagy. Cell Mol Biol Lett 2020;25:48. [PMID: 33292165 DOI: 10.1186/s11658-020-00241-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 10 |
Chen RL, Zhou JX, Cao Y, Sun LL, Su S, Deng XJ, Lin JT, Xiao ZW, Chen ZZ, Wang SY, Lin LZ. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival. Front Immunol 2020;11:1933. [PMID: 33072067 DOI: 10.3389/fimmu.2020.01933] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Zhou H, Zhang H, Shi M, Wang J, Huang Z, Shi J. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Int Immunopharmacol 2020;88:106856. [PMID: 32777677 DOI: 10.1016/j.intimp.2020.106856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 12 |
Caccamo D, Currò M, Ientile R, Verderio EA, Scala A, Mazzaglia A, Pennisi R, Musarra-Pizzo M, Zagami R, Neri G, Rosmini C, Potara M, Focsan M, Astilean S, Piperno A, Sciortino MT. Intracellular Fate and Impact on Gene Expression of Doxorubicin/Cyclodextrin-Graphene Nanomaterials at Sub-Toxic Concentration. Int J Mol Sci 2020;21:E4891. [PMID: 32664456 DOI: 10.3390/ijms21144891] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 13 |
Cho HJ, Zhao J, Jung SW, Ladewig E, Kong DS, Suh YL, Lee Y, Kim D, Ahn SH, Bordyuh M, Kang HJ, Sa JK, Seo YJ, Kim ST, Lim DH, Dho YS, Lee JI, Seol HJ, Choi JW, Park WY, Park CK, Rabadan R, Nam DH. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma. Neuro Oncol 2019;21:47-58. [PMID: 30085274 DOI: 10.1093/neuonc/noy123] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 14 |
Xiong Y, Ran J, Xu L, Tong Z, Adel Abdo MS, Ma C, Xu K, He Y, Wu Z, Chen Z, Hu P, Jiang L, Bao J, Chen W, Wu L. Reactivation of NR4A1 Restrains Chondrocyte Inflammation and Ameliorates Osteoarthritis in Rats. Front Cell Dev Biol 2020;8:158. [PMID: 32258036 DOI: 10.3389/fcell.2020.00158] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 15 |
Kønig SM, Rissler V, Terkelsen T, Lambrughi M, Papaleo E. Alterations of the interactome of Bcl-2 proteins in breast cancer at the transcriptional, mutational and structural level. PLoS Comput Biol 2019;15:e1007485. [PMID: 31825969 DOI: 10.1371/journal.pcbi.1007485] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 16 |
Xiong J, Kuang X, Lu T, Liu X, Cheng B, Wang W, Wei D, Li X, Zhang Z, Fang Q, Wu D, Wang J. Fenretinide-induced Apoptosis of Acute Myeloid Leukemia Cells via NR4A1 Translocation into Mitochondria and Bcl-2 Transformation. J Cancer 2019;10:6767-78. [PMID: 31839811 DOI: 10.7150/jca.32167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Pendergrass HA, May AE. Natural Product Type III Secretion System Inhibitors. Antibiotics (Basel) 2019;8:E162. [PMID: 31554164 DOI: 10.3390/antibiotics8040162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 18 |
Katsara O, Attur M, Kolupaeva V. Control of cartilage homeostasis and osteoarthritis progression by mTORC1/4E-BP/eIF4E axis.. [DOI: 10.1101/768457] [Reference Citation Analysis]
|
| 19 |
Kønig SM, Rissler V, Terkelsen T, Lambrughi M, Papaleo E. Alterations of the pro-survival Bcl-2 protein interactome in breast cancer at the transcriptional, mutational and structural level.. [DOI: 10.1101/695379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 20 |
Huang M, Xie X, Song X, Gu S, Chang X, Su T, Liang B, Huang D. MiR-506 Suppresses Colorectal Cancer Development by Inhibiting Orphan Nuclear Receptor NR4A1 Expression. J Cancer 2019;10:3560-70. [PMID: 31293661 DOI: 10.7150/jca.28272] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 21 |
Chen X, Cao X, Tu X, Alitongbieke G, Xia Z, Li X, Chen Z, Yin M, Xu D, Guo S, Li Z, Chen L, Zhang X, Xu D, Gao M, Liu J, Zeng Z, Zhou H, Su Y, Zhang XK. BI1071, a Novel Nur77 Modulator, Induces Apoptosis of Cancer Cells by Activating the Nur77-Bcl-2 Apoptotic Pathway. Mol Cancer Ther 2019;18:886-99. [PMID: 30926635 DOI: 10.1158/1535-7163.MCT-18-0918] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 22 |
Liu N, Wu Z, Chen A, Chai D, Li L, Zhang L, Zheng J. ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells. J Cell Mol Med 2019;23:3520-9. [PMID: 30821058 DOI: 10.1111/jcmm.14251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Sun R, Bao MY, Long X, Yuan Y, Wu MM, Li X, Bao JK. Metabolic gene NR4A1 as a potential therapeutic target for non-smoking female non-small cell lung cancer patients. Thorac Cancer 2019;10:715-27. [PMID: 30806032 DOI: 10.1111/1759-7714.12989] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 24 |
Zhong C, Mai Y, Gao H, Zhou W, Zhou D. Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells. Gene 2019;693:61-8. [PMID: 30641217 DOI: 10.1016/j.gene.2018.12.072] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Zhang C, Liu J, Tao F, Lu Y, He Q, Zhao L, Ou R, Xu Y, Li W. Retracted Article: The nuclear export of TR3 mediated gambogic acid-induced apoptosis in cervical cancer cells through mitochondrial dysfunction. RSC Adv 2019;9:11855-64. [DOI: 10.1039/c8ra10542a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 26 |
Fedorova O, Petukhov A, Daks A, Shuvalov O, Leonova T, Vasileva E, Aksenov N, Melino G, Barlev NA. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. Oncogene 2019;38:2108-22. [PMID: 30455429 DOI: 10.1038/s41388-018-0566-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 27 |
Tel-Karthaus N, Kers-Rebel ED, Looman MW, Ichinose H, de Vries CJ, Ansems M. Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function. Front Immunol 2018;9:1797. [PMID: 30123220 DOI: 10.3389/fimmu.2018.01797] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 28 |
Zhang L, Wang Q, Liu W, Liu F, Ji A, Li Y. The Orphan Nuclear Receptor 4A1: A Potential New Therapeutic Target for Metabolic Diseases. J Diabetes Res 2018;2018:9363461. [PMID: 30013988 DOI: 10.1155/2018/9363461] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 29 |
Zhang L, Liu W, Wang Q, Li Q, Wang H, Wang J, Teng T, Chen M, Ji A, Li Y. New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy. Molecules 2018;23:E565. [PMID: 29498706 DOI: 10.3390/molecules23030565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 30 |
Фонин А, Сударикова А. МЕТИЛТРАНСФЕРАЗА SET7/9 РЕГУЛИРУЕТ ЭКСПРЕССИЮ ЯДЕРНОГО РЕЦЕПТОРА NR4A1, "Цитология". Tsitologiya 2018. [DOI: 10.7868/s0041377118100041] [Reference Citation Analysis]
|
| 31 |
Zhang D, Chen Z, Hu C, Yan S, Li Z, Lian B, Xu Y, Ding R, Zeng Z, Zhang X, Su Y. Celastrol binds to its target protein via specific noncovalent interactions and reversible covalent bonds. Chem Commun 2018;54:12871-4. [DOI: 10.1039/c8cc06140h] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 32 |
Zhu B, Yang JR, Jia Y, Zhang P, Shen L, Li XL, Li J, Wang B. Overexpression of NR4A1 is associated with tumor recurrence and poor survival in non-small-cell lung carcinoma. Oncotarget 2017;8:113977-86. [PMID: 29371962 DOI: 10.18632/oncotarget.23048] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 33 |
Hu M, Luo Q, Alitongbieke G, Chong S, Xu C, Xie L, Chen X, Zhang D, Zhou Y, Wang Z, Ye X, Cai L, Zhang F, Chen H, Jiang F, Fang H, Yang S, Liu J, Diaz-Meco MT, Su Y, Zhou H, Moscat J, Lin X, Zhang XK. Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy. Mol Cell 2017;66:141-153.e6. [PMID: 28388439 DOI: 10.1016/j.molcel.2017.03.008] [Cited by in Crossref: 149] [Cited by in F6Publishing: 156] [Article Influence: 24.8] [Reference Citation Analysis]
|
| 34 |
Lee HS, Safe S, Lee SO. Inactivation of the orphan nuclear receptor NR4A1 contributes to apoptosis induction by fangchinoline in pancreatic cancer cells. Toxicol Appl Pharmacol 2017;332:32-9. [PMID: 28754437 DOI: 10.1016/j.taap.2017.07.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 35 |
Liu J, Wang GH, Duan YH, Dai Y, Bao Y, Hu M, Zhou YQ, Li M, Jiang F, Zhou H, Yao XS, Zhang XK. Modulation of the Nur77-Bcl-2 apoptotic pathway by p38α MAPK. Oncotarget 2017;8:69731-45. [PMID: 29050237 DOI: 10.18632/oncotarget.19227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 36 |
Li XM, Yang TY, He XS, Wang JR, Gan WJ, Zhang S, Li JM, Wu H. Orphan nuclear receptor Nur77 inhibits poly (I:C)-triggered acute liver inflammation by inducing the ubiquitin-editing enzyme A20. Oncotarget 2017;8:61025-35. [PMID: 28977843 DOI: 10.18632/oncotarget.17731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 37 |
Li XM, Wang JR, Shen T, Gao SS, He XS, Li JN, Yang TY, Zhang S, Gan WJ, Li JM, Wu H. Nur77 deficiency in mice accelerates tumor invasion and metastasis by facilitating TNFα secretion and lowering CSF-1R expression. PLoS One 2017;12:e0171347. [PMID: 28170411 DOI: 10.1371/journal.pone.0171347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 38 |
Hu H, Lin C, Ao M, Ji Y, Tang B, Zhou X, Fang M, Zeng J, Wu Z. Synthesis and biological evaluation of 1-(2-(adamantane-1-yl)-1H-indol-5-yl)-3-substituted urea/thiourea derivatives as anticancer agents. RSC Adv 2017;7:51640-51. [DOI: 10.1039/c7ra08149a] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 39 |
Delgado E, Boisen MM, Laskey R, Chen R, Song C, Sallit J, Yochum ZA, Andersen CL, Sikora MJ, Wagner J, Safe S, Elishaev E, Lee A, Edwards RP, Haluska P, Tseng G, Schurdak M, Oesterreich S. High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome. Gynecol Oncol 2016;141:348-56. [PMID: 26946093 DOI: 10.1016/j.ygyno.2016.02.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 40 |
Tenga A, Beard JA, Takwi A, Wang YM, Chen T. Regulation of Nuclear Receptor Nur77 by miR-124. PLoS One 2016;11:e0148433. [PMID: 26840408 DOI: 10.1371/journal.pone.0148433] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 41 |
Wu H, Li XM, Wang JR, Gan WJ, Jiang FQ, Liu Y, Zhang XD, He XS, Zhao YY, Lu XX. NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis. J Pathol. 2016;238:457-469. [PMID: 26564988 DOI: 10.1002/path.4670] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 42 |
Xie L, Jiang F, Zhang X, Alitongbieke G, Shi X, Meng M, Xu Y, Ren A, Wang J, Cai L, Zhou Y, Xu Y, Su Y, Liu J, Zeng Z, Wang G, Zhou H, Chen QC, Zhang XK. Honokiol sensitizes breast cancer cells to TNF-α induction of apoptosis by inhibiting Nur77 expression. Br J Pharmacol 2016;173:344-56. [PMID: 26505879 DOI: 10.1111/bph.13375] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 43 |
Li Y, Carrillo JA, Ding Y, He Y, Zhao C, Liu J, Liu GE, Zan L, Song J. Transcriptomic Profiling of Spleen in Grass-Fed and Grain-Fed Angus Cattle. PLoS One 2015;10:e0135670. [PMID: 26367387 DOI: 10.1371/journal.pone.0135670] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 44 |
Lanig H, Reisen F, Whitley D, Schneider G, Banting L, Clark T. In Silico Adoption of an Orphan Nuclear Receptor NR4A1. PLoS One 2015;10:e0135246. [PMID: 26270486 DOI: 10.1371/journal.pone.0135246] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 45 |
Chen F, Chen J, Lin J, Cheltsov AV, Xu L, Chen Y, Zeng Z, Chen L, Huang M, Hu M, Ye X, Zhou Y, Wang G, Su Y, Zhang L, Zhou F, Zhang XK, Zhou H. NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell. Protein Cell 2015;6:654-66. [PMID: 26156677 DOI: 10.1007/s13238-015-0178-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 46 |
Li XM, Lu XX, Xu Q, Wang JR, Zhang S, Guo PD, Li JM, Wu H. Nur77 deficiency leads to systemic inflammation in elderly mice. J Inflamm (Lond) 2015;12:40. [PMID: 26113803 DOI: 10.1186/s12950-015-0085-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 47 |
Hedrick E, Lee SO, Kim G, Abdelrahim M, Jin UH, Safe S, Abudayyeh A. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma. PLoS One 2015;10:e0128308. [PMID: 26035713 DOI: 10.1371/journal.pone.0128308] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 48 |
Willis S, De P, Dey N, Long B, Young B, Sparano JA, Wang V, Davidson NE, Leyland-Jones BR. Enriched transcription factor signatures in triple negative breast cancer indicates possible targeted therapies with existing drugs. Meta Gene 2015;4:129-41. [PMID: 26005638 DOI: 10.1016/j.mgene.2015.04.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 49 |
Safe S, Jin UH, Morpurgo B, Abudayyeh A, Singh M, Tjalkens RB. Nuclear receptor 4A (NR4A) family - orphans no more. J Steroid Biochem Mol Biol 2016;157:48-60. [PMID: 25917081 DOI: 10.1016/j.jsbmb.2015.04.016] [Cited by in Crossref: 110] [Cited by in F6Publishing: 116] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 50 |
De Miranda BR, Popichak KA, Hammond SL, Jorgensen BA, Phillips AT, Safe S, Tjalkens RB. The Nurr1 Activator 1,1-Bis(3'-Indolyl)-1-(p-Chlorophenyl)Methane Blocks Inflammatory Gene Expression in BV-2 Microglial Cells by Inhibiting Nuclear Factor κB. Mol Pharmacol 2015;87:1021-34. [PMID: 25858541 DOI: 10.1124/mol.114.095398] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 51 |
Safe S, Lee S, Meng C, Zhou B. NR4A Orphan Receptors as Drug Targets. Targeted Therapy of Acute Myeloid Leukemia 2015. [DOI: 10.1007/978-1-4939-1393-0_26] [Reference Citation Analysis]
|
| 52 |
Paillasse MR, de Medina P. The NR4A nuclear receptors as potential targets for anti-aging interventions. Med Hypotheses 2015;84:135-40. [PMID: 25543265 DOI: 10.1016/j.mehy.2014.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 53 |
De Miranda BR, Popichak KA, Hammond SL, Miller JA, Safe S, Tjalkens RB. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease. Toxicol Sci 2015;143:360-73. [PMID: 25406165 DOI: 10.1093/toxsci/kfu236] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 54 |
Beard JA, Tenga A, Chen T. The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer. Cell Signal 2015;27:257-66. [PMID: 25446259 DOI: 10.1016/j.cellsig.2014.11.009] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 55 |
Huo Y, Yi B, Chen M, Wang N, Chen P, Guo C, Sun J. Induction of Nur77 by hyperoside inhibits vascular smooth muscle cell proliferation and neointimal formation. Biochem Pharmacol 2014;92:590-8. [PMID: 25316569 DOI: 10.1016/j.bcp.2014.09.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 56 |
Zhou Y, Zhao W, Xie G, Huang M, Hu M, Jiang X, Zeng D, Liu J, Zhou H, Chen H, Wang GH, Zhang XK. Induction of Nur77-dependent apoptotic pathway by a coumarin derivative through activation of JNK and p38 MAPK. Carcinogenesis 2014;35:2660-9. [PMID: 25187486 DOI: 10.1093/carcin/bgu186] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 57 |
Lee SO, Li X, Hedrick E, Jin UH, Tjalkens RB, Backos DS, Li L, Zhang Y, Wu Q, Safe S. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells. Mol Endocrinol 2014;28:1729-39. [PMID: 25099012 DOI: 10.1210/me.2014-1102] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 58 |
Wang JR, Gan WJ, Li XM, Zhao YY, Li Y, Lu XX, Li JM, Wu H. Orphan nuclear receptor Nur77 promotes colorectal cancer invasion and metastasis by regulating MMP-9 and E-cadherin. Carcinogenesis. 2014;35:2474-2484. [PMID: 25064356 DOI: 10.1093/carcin/bgu157] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 59 |
Jackson WD, Woollard KJ. Targeting monocyte and macrophage subpopulations for immunotherapy: a patent review (2009 - 2013). Expert Opin Ther Pat 2014;24:779-90. [PMID: 24773534 DOI: 10.1517/13543776.2014.914495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 60 |
Lee SO, Jin UH, Kang JH, Kim SB, Guthrie AS, Sreevalsan S, Lee JS, Safe S. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res 2014;12:527-38. [PMID: 24515801 DOI: 10.1158/1541-7786.MCR-13-0567] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 61 |
Safe S, Jin UH, Hedrick E, Reeder A, Lee SO. Minireview: role of orphan nuclear receptors in cancer and potential as drug targets. Mol Endocrinol. 2014;28:157-172. [PMID: 24295738 DOI: 10.1210/me.2013-1291] [Cited by in Crossref: 113] [Cited by in F6Publishing: 114] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 62 |
Campos-Melo D, Galleguillos D, Sánchez N, Gysling K, Andrés ME. Nur transcription factors in stress and addiction. Front Mol Neurosci 2013;6:44. [PMID: 24348325 DOI: 10.3389/fnmol.2013.00044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 63 |
Luchino J, Hocine M, Amoureux MC, Gibert B, Bernet A, Royet A, Treilleux I, Lécine P, Borg JP, Mehlen P, Chauvet S, Mann F. Semaphorin 3E suppresses tumor cell death triggered by the plexin D1 dependence receptor in metastatic breast cancers. Cancer Cell 2013;24:673-85. [PMID: 24139859 DOI: 10.1016/j.ccr.2013.09.010] [Cited by in Crossref: 76] [Cited by in F6Publishing: 66] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 64 |
Andey T, Patel A, Jackson T, Safe S, Singh M. 1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model. Eur J Pharm Sci 2013;50:227-41. [PMID: 23892137 DOI: 10.1016/j.ejps.2013.07.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 65 |
Wilson AJ, Liu AY, Roland J, Adebayo OB, Fletcher SA, Slaughter JC, Saskowski J, Crispens MA, Jones HW 3rd, James S, Fadare O, Khabele D. TR3 modulates platinum resistance in ovarian cancer. Cancer Res 2013;73:4758-69. [PMID: 23720056 DOI: 10.1158/0008-5472.CAN-12-4560] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 66 |
Lin H, Lin Q, Liu M, Lin Y, Wang X, Chen H, Xia Z, Lu B, Ding F, Wu Q, Wang H. PKA/Smurf1 signaling-mediated stabilization of Nur77 is required for anticancer drug cisplatin-induced apoptosis. Oncogene 2014;33:1629-39. [DOI: 10.1038/onc.2013.116] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 67 |
De Miranda BR, Miller JA, Hansen RJ, Lunghofer PJ, Safe S, Gustafson DL, Colagiovanni D, Tjalkens RB. Neuroprotective efficacy and pharmacokinetic behavior of novel anti-inflammatory para-phenyl substituted diindolylmethanes in a mouse model of Parkinson's disease. J Pharmacol Exp Ther 2013;345:125-38. [PMID: 23318470 DOI: 10.1124/jpet.112.201558] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 68 |
Duszka K, Bogner-Strauss JG, Hackl H, Rieder D, Neuhold C, Prokesch A, Trajanoski Z, Krogsdam AM. Nr4a1 is required for fasting-induced down-regulation of Pparγ2 in white adipose tissue. Mol Endocrinol 2013;27:135-49. [PMID: 23250487 DOI: 10.1210/me.2012-1248] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 69 |
Xia Z, Cao X, Rico-Bautista E, Yu J, Chen L, Chen J, Bobkov A, Wolf DA, Zhang XK, Dawson MI. Relative impact of 3- and 5-hydroxyl groups of cytosporone B on cancer cell viability. Medchemcomm 2013;4:332-9. [PMID: 24795803 DOI: 10.1039/C2MD20243C] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 70 |
To SK, Zeng JZ, Wong AS. Nur77: a potential therapeutic target in cancer. Expert Opin Ther Targets 2012;16:573-85. [PMID: 22537097 DOI: 10.1517/14728222.2012.680958] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 71 |
Li X, Lee SO, Safe S. Structure-dependent activation of NR4A2 (Nurr1) by 1,1-bis(3’-indolyl)-1-(aromatic)methane analogs in pancreatic cancer cells. Biochem Pharmacol. 2012;83:1445-1455. [PMID: 22405837 DOI: 10.1016/j.bcp.2012.02.021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 72 |
Strøm BO, Paulsen RE. Apoptosis inducer NGFI-B is degraded by the proteasome and stabilized by treatment with EGF. Biochem Biophys Res Commun 2012;417:1292-7. [PMID: 22234305 DOI: 10.1016/j.bbrc.2011.12.132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 73 |
Banerjee S, Kong D, Wang Z, Bao B, Hillman GG, Sarkar FH. Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic. Mutat Res 2011;728:47-66. [PMID: 21703360 DOI: 10.1016/j.mrrev.2011.06.001] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 6.8] [Reference Citation Analysis]
|
